|
Erez Vigodman
|
|
Erez Vigodman (; born 1959) is an Israeli businessman, the former president and CEO of Teva Pharmaceutical Industries, the largest generic drug manufacturer in the world. Career Vigodman served as the CEO of Makhteshim Agan until joining Teva, and was president and CEO of Strauss Group prior to this. In February 2017, Teva announced that Vigodman was stepping down as CEO with immediate effect and would be replace on an interim basis by the chairman, Yitzhak Peterburg, and Sol Barer would be the new chairman. This was a consequence of the $40 billion acquisition of Activis' generics division, which sent Teva spiralling down and saw its market capitalisation cut in half in less than a year. He is succeeded by Kåre Schultz, a Danish pharmaceutical veteran. |
| < Prev | Next > |
|---|
Main Menu
| Home |
| Articles |
| Search |
| Submit Article |
| Contact Us |
| Donate to Wikibin |
